Global Radiopharmaceuticals Market to Reflect a Significant CAGR of 9.30% by Global Analysis of Key Players Like Cardinal Health, Mallinckrodt., General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.p.A.

Press Release

Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities. This licensing includes compliance both with governing radioactive materials and with those regulations governing pharmaceutical preparations. Additional regulations may apply for issues such as transportation or dispensing of radiopharmaceuticals.

Global Radiopharmaceuticals Market  report includes historic data with forecast years from 2019-2026. The global radiopharmaceuticals market is expected to rise to an estimated value of USD 11.85 billion by 2026 registering a substantial CAGR of 9.30% in the forecast period of 2019-2026 by  major market competitors like  Cardinal Health, Mallinckrodt., General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG etc.

Click the link to Get a Free Sample Copy of the Report @

Global Radiopharmaceuticals Market segmented By Type ,Application , Procedural Volumes , , End User ,Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Key Developments in the Market:

  • In April 2018, Cyclopharma has entered into an agreement to sell all its radiopharmaceutical manufacturing and commercialization activities to Curium. With this acquisition, Curium would be able to expand its manufacturing, development and designs of new compounds, thereby expanding its radiopharmaceutical business to soon become a world leader
  • In January 2018, Advanced Accelerator Application (AAA) received the permission from USA’s FDA to use Lutathera for treating a type of cancer which affects pancreas/ gastrointestinal tract i.e. Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). This is the very first time approval has been given to use a radiopharmaceutical for treating GEP-NETs. Thus, with this approval, radiopharmaceuticals have now been approved to treat a whole new disease, thereby expanding its market, which would significantly contribute towards the growth of radiopharmaceuticals market globally in the forecasted period

Competitive Analysis: Global Radiopharmaceuticals Market

Global radiopharmaceuticals market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of radiopharmaceuticals for Global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Market Drivers

  • Increasing prevalence of cancer and cardiovascular chronic diseases, which is creating need for early diagnosis and treatment
  • Rising healthcare expenditure boosts the growth of this market
  • Growing awareness about the benefits of radiopharmaceuticals amongst healthcare providers also expands the growth of this market
  • Technological advancements an developments which allows the  use of radio-labeled peptides and monoclonal antibodies for the diagnosis and treatment of cancerous tumors
  • Increasing preference of SPECT and PET scans and growing preference of disease targeted cancer therapy

Market Restraints

  • Stringent regulatory guidelines and high cost of devices using radioisotopes
  • Short half-life of radiopharmaceutical

 Table of Contents:

 Chapter 1: Study Coverage

Chapter 2: Executive Summary

Chapter 3: Global Radiopharmaceuticals Market Size-by Manufacturers

Chapter 4: Radiopharmaceuticals Production-by Regions

Chapter 5: Radiopharmaceuticals Consumption-by Regions

Chapter 6: Global Radiopharmaceuticals Market Size-by Type

Chapter 7: Global Radiopharmaceuticals Market Size-by Application

Chapter 8: Manufacturers Profiles

Chapter 9: Production Forecasts

Chapter 10: Consumption Forecast

Chapter 11: Upstream, Industry Chain and Downstream Customers Analysis

Chapter 12: Opportunities & Challenges, Threat and Affecting Factors

Chapter 13: Key Findings

Chapter 14: Appendix

 Request Complete TOC Of this Report @

Market Segmentation:Global Radiopharmaceuticals Market segmented

By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine),

By Application

  • Diagnostic Applications
    • Spect Applications
      • Cardiology
      • Lymphoma
      • Neurology
      • Thyroid
      • Other Spect Applications
    • Pet Applications
      • Oncology
      • Cardiology
      • Neurology
      • Other Pet Applications
    • Therapeutic Applications
      • Thyroid
      • Bone Metastasis
      • Lymphoma
      • Endocrine Tumors
      • Other Therapeutic Applications

By Procedural Volume

  • Diagnostic Procedures
    • Spect Radiopharmaceuticals
    • Pet Radiopharmaceuticals
  • Therapeutic Procedures
    • Beta Emitters
    • Alpha Emitters
    • Brachytherapy Isotopes

By Source

  • Nuclear Reactors
  • Cyclotrons

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Cancer Research Institutes
  • Others

 Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Reasons to Purchase this Report

  • Current and future of global radiopharmaceuticals market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players


Enquire Here Get customization & check discount for report @